ANTHRAX OUTBREAK INVESTIGATION AMONG HUMANS AND ANIMALS IN NORTHERN GHANA: CASE REPORT

Background: Anthrax is a bacterial infection that affects both animals and humans. It is caused by gram positive bacterium, Bacillus anthracis. It is an acute, specific infectious disease of mainly grass eating animals including cattle, sheep, goats and pigs and common in areas where livestock are raised. It affects humans when exposed to the fur, blood or carcass of an infected animal. A single case of anthrax in any given geographical area has the potential to result in an outbreak in both humans and animals if not handled effectively and in a timely manner. Anthrax disease occurrence is irregular in the northern regions of Ghana with yearly outbreaks. Case Study Awoonor-Williams et al.; IJTDH, 12(2): 1-11, 2016; Article no.IJTDH.22359 2 Case Presentation: We report an outbreak investigation of anthrax in both humans and animals in April, 2013. The outbreak was from Gbengo community in the Bawku West district of Upper East Region of northern Ghana. There were three human deaths due to this particular outbreak, representing a case fatality rate of 0.032 (per 1000 of a total district population 94,034). Laboratory confirmed anthrax (Bacillus anthracis) with a very high case fatality rate (100%) also affected domesticated herbivorous mammals (17 cattle 3 sheep, 2 goats) of all ages and sexes. Conclusion: The case revealed that anthrax outbreaks remain a major problem in northern Ghana with high case fatality rate. It also highlights the importance of forecasting anthrax outbreak. In response, public health action to anthrax control with continued public health programming to avert future outbreaks is needed. In addition, both health systems and veterinary services need to collaborate in anthrax surveillance for early case detection and response to prevent deaths.

[1]  M. Mohamadzadeh,et al.  New insights into gastrointestinal anthrax infection. , 2015, Trends in molecular medicine.

[2]  Haiying Chen,et al.  Clinical and epidemiological investigation of a fatal anthrax case in China. , 2015, Journal of infection in developing countries.

[3]  Yun-zhou Yu,et al.  Potentiation of anthrax vaccines using protective antigen-expressing viral replicon vectors. , 2015, Immunology letters.

[4]  Theodore W Randolph,et al.  Glassy-state stabilization of a dominant negative inhibitor anthrax vaccine containing aluminum hydroxide and glycopyranoside lipid A adjuvants. , 2015, Journal of pharmaceutical sciences.

[5]  A. Goel.  Anthrax: A disease of biowarfare and public health importance. , 2015, World journal of clinical cases.

[6]  D. Uçmak,et al.  Cutaneous anthrax in Southeast Anatolia of Turkey , 2015, Cutaneous and ocular toxicology.

[7]  T. Migone,et al.  Added Benefit of Raxibacumab to Antibiotic Treatment of Inhalational Anthrax , 2014, Antimicrobial Agents and Chemotherapy.

[8]  R. Breiman,et al.  Establishing a One Health office in Kenya , 2014, The Pan African medical journal.

[9]  B. Parcell,et al.  Confirmed Bacillus anthracis Infection among Persons Who Inject Drugs, Scotland, 2009–2010 , 2014, Emerging infectious diseases.

[10]  A. Hoffmaster,et al.  Investigation and Control of Anthrax Outbreak at the Human–Animal Interface, Bhutan, 2010 , 2014, Emerging infectious diseases.

[11]  J. Blackburn,et al.  Dances with Anthrax: Wolves (Canis lupus) Kill Anthrax Bacteremic Plains Bison (Bison bison bison) in Southwestern Montana , 2014, Journal of wildlife diseases.

[12]  M. Alam,et al.  Cutaneous anthrax in a school teacher. , 2014, Mymensingh Medical Journal.

[13]  H. Ogawa,et al.  Genome Sequence of a Bacillus anthracis Outbreak Strain from Zambia, 2011 , 2014, Genome Announcements.

[14]  N. Kissoon,et al.  Infections of the developing world. , 2013, Critical care clinics.

[15]  A. Nicholson,et al.  Inhalational anthrax in a vaccinated soldier , 2013, European Respiratory Journal.

[16]  J. Metcalf,et al.  The sepsis model: an emerging hypothesis for the lethality of inhalation anthrax , 2013, Journal of cellular and molecular medicine.

[17]  N. Duesbery,et al.  A Human/Murine Chimeric Fab Antibody Neutralizes Anthrax Lethal Toxin In Vitro , 2013, Clinical & developmental immunology.

[18]  C. Packer,et al.  Predictability of anthrax infection in the Serengeti, Tanzania. , 2011, The Journal of applied ecology.

[19]  Mihai Pop,et al.  Bacillus anthracis comparative genome analysis in support of the Amerithrax investigation , 2011, Proceedings of the National Academy of Sciences.

[20]  N. Twenhafel.  Pathology of Inhalational Anthrax Animal Models , 2010, Veterinary pathology.

[21]  J. Esmaeili,et al.  Two rare presentations of fatal anthrax: meningeal and intestinal. , 2010, Archives of Iranian medicine.

[22]  H. Hatami,et al.  Two cases of gastrointestinal anthrax with an unusual presentation from Kermanshah (western Iran). , 2010, Archives of Iranian medicine.

[23]  M. Hugh-jones,et al.  The ecology of Bacillus anthracis. , 2009, Molecular aspects of medicine.

[24]  C. Langston.  Postexposure management and treatment of anthrax in dogs—Executive councils of the American academy of veterinary pharmacology and therapeutics and the American college of veterinary clinical pharmacology , 2005, The AAPS Journal.

[25]  D. Dragon,et al.  Natural Dissemination of Bacillus anthracis Spores in Northern Canada , 2005, Applied and Environmental Microbiology.

[26]  Thomas V Inglesby,et al.  Management of anthrax. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  O. Kurt,et al.  A Case of Anthrax Meningitis , 2002, Scandinavian journal of infectious diseases.

[28]  B. Akanmori,et al.  Human behavioural factors implicated in outbreaks of human anthrax in the Tamale municipality of northern Ghana. , 2000, Acta tropica.

[29]  Donald A. Henderson,et al.  Anthrax: The Investigation of a Deadly Outbreak , 2000, Nature Medicine.

[30]  B. Cherkasskiy.  A national register of historic and contemporary anthrax foci , 1999, Journal of applied microbiology.

[31]  R. Daniel,et al.  Acidophilic and thermophilic Bacillus strains from geothermally heated antarctic soil , 1989 .

[32]  A. Abdollahi,et al.  Gastrointestinal anthrax: clinical experience in 5 cases. , 2013, Caspian journal of internal medicine.

[33]  N. Karadaǧ,et al.  Investigation and analysis of a human orf outbreak among people living on the same farm. , 2011, The new microbiologica.

[34]  S. Leppla,et al.  Pathophysiology of anthrax. , 2009, Frontiers in bioscience.

[35]  J. Patočka,et al.  Anthrax toxin characterization. , 2002, Acta medica.

[36]  B. Elkin,et al.  An Overview of Early Anthrax Outbreaks in Northern Canada: Field Reports of the Health of Animals Branch, Agriculture Canada, 1962-71 , 2001 .

[37]  B. Ivins,et al.  Plasmids, Pasteur, and Anthrax , 1983 .